Novo Nordisk episode, we covered the business of Ozempic, the GLP-1 taking the world by storm. On this episode, we dive in"> Novo Nordisk episode, we covered the business of Ozempic, the GLP-1 taking the world by storm. On this episode, we dive in"> Novo Nordisk episode, we covered the business of Ozempic, the GLP-1 taking the world by storm. On this episode, we dive in">
Acquired LPs
Acquired LPs

The Scientific Journey Behind Ozempic (with Lotte Bjerre Knudsen, Novo Nordisk's Chief Scientific Advisor)

Mar 06, 2024 · 1h 0m

<p>On our <a href="https://www.acquired.fm/episodes/novo-nordisk-ozempic">Novo Nordisk episode</a>, we covered the business of Ozempic, the GLP-1 taking the world by storm. On this episode, we dive into the <em>science</em> of the molecule semaglutide (and its predecessor liraglutide) with the world expert on the topic, Lotte Bjerre Knudsen. Lotte is Novo Nordisk’s Chief Scientific Advisor, and led the research group back in the early 1990s that first invented the molecule. A few topics from our conversation:</p><ul><li>The science behind what is happening in the …

Šis epizodas dar nebuvo tranzitinis

Naudokite STT.ai, kad perrašytumėte šį epizodą su AI. Gaukite tikslų tekstą su garsiakalbio aptikimu, žymomis ir eksportuokite keliais formatais.

Garsiakalbio nustatymas Žodžių lygio žymos Eksportuoti kaip SRT, TXT, JSON

Daugiau epizodų